Skip to content

Educational reference only. Not medical advice, diagnosis, or treatment, and not dosing, injection, or purchasing guidance.Medical disclaimer

CJC-1295

These sentences are taken from FDA’s compounding-risk page and, where noted, the July 2026 advisory-committee agenda. They are not a finding that a substance works.

  • CJC-1295 is on the withdrawn-nomination list. FDA says compounded drugs containing it may pose an immunogenicity risk for certain routes and may be difficult to characterize.
  • FDA says it has identified serious adverse events associated with CJC-1295, including increased heart rate and a systemic vasodilatory reaction, and that available clinical data are limited.

Legal effect beyond the words on those pages is not interpreted. No animal or human study is summarized, because none was opened.

This page does not give doses, titration schedules, injection or implantation technique, preparation steps, or places to purchase a product.

Page record

  • Type: Compound
  • Domain: peptides
  • Evidence: Not rated
  • Status: reviewed
  • Last reviewed: 2026-11-20

Sources

Referenced by

A link from another wiki page is not evidence. Facts should point at the sources above.